Search research articles
Contact Us
Filters
Showing results (631-640 of 637) with videos related to
Page
of 64
Sort By:
You have reached the last page of results.
This site can display upto 637 results.
Nature Communications
|
December 6, 2023
Inhibiting stromal Class I HDACs curbs pancreatic cancer progression
Gaoyang Liang, Tae Gyu Oh, Nasun Hah, et al.
Nature Metabolism
|
October 1, 2025
DDHD2 provides a flux of saturated fatty acids for neuronal energy and function
Saber H Saber, Nyakuoy Yak, Xuan Ling Hilary Yong, et al.
Journal of Medicinal Chemistry
|
May 14, 2015
Discovery of N-(4-(3-(2-aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), a highly selective, orally bioavailable inhibitor of aurora kinases with activity against multidrug-resistant cancer cell lines
Stephanie Geuns-Meyer, Victor J Cee, Holly L Deak, et al.
Biorxiv : the Preprint Server for Biology
|
June 5, 2026
CA19-9 induces microenvironment remodeling in pancreatic ductal adenocarcinoma
Jasper Hsu, Hyemin Song, Satoshi Ogawa, et al.
Neuro-Oncology
|
August 12, 2021
Multimodal platform for assessing drug distribution and response in clinical trials
Begoña G C Lopez, Ishwar N Kohale, Ziming Du, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Chronic pancreatitis patient-derived organoids reveal new paths to precision therapeutics
Victoria Osorio-Vasquez, Jonathan Zhu, Jan C Lumibao, et al.
Cell Stem Cell
|
June 30, 2026
Patient-derived organoids reveal ductal dysfunction and CFTR-modulator responses in chronic pancreatitis
Victoria Osorio-Vasquez, Jonathan Zhu, Jan C Lumibao, et al.
Page
of 64
Search research articles
Search
Showing results (631-640 of 637) with videos related to
Sort By:
Page
of 64
You have reached the last page of results.
This site can display upto 637 results.
Nature Communications
|
December 6, 2023
Inhibiting stromal Class I HDACs curbs pancreatic cancer progression
Gaoyang Liang, Tae Gyu Oh, Nasun Hah, et al.
Nature Metabolism
|
October 1, 2025
DDHD2 provides a flux of saturated fatty acids for neuronal energy and function
Saber H Saber, Nyakuoy Yak, Xuan Ling Hilary Yong, et al.
Journal of Medicinal Chemistry
|
May 14, 2015
Discovery of N-(4-(3-(2-aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), a highly selective, orally bioavailable inhibitor of aurora kinases with activity against multidrug-resistant cancer cell lines
Stephanie Geuns-Meyer, Victor J Cee, Holly L Deak, et al.
Biorxiv : the Preprint Server for Biology
|
June 5, 2026
CA19-9 induces microenvironment remodeling in pancreatic ductal adenocarcinoma
Jasper Hsu, Hyemin Song, Satoshi Ogawa, et al.
Neuro-Oncology
|
August 12, 2021
Multimodal platform for assessing drug distribution and response in clinical trials
Begoña G C Lopez, Ishwar N Kohale, Ziming Du, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Chronic pancreatitis patient-derived organoids reveal new paths to precision therapeutics
Victoria Osorio-Vasquez, Jonathan Zhu, Jan C Lumibao, et al.
Cell Stem Cell
|
June 30, 2026
Patient-derived organoids reveal ductal dysfunction and CFTR-modulator responses in chronic pancreatitis
Victoria Osorio-Vasquez, Jonathan Zhu, Jan C Lumibao, et al.
Page
of 64